| References | Journal | Year | |
Performance of plasma p-tau217 for the detection of amyloid-β positivity in a memory clinic cohort using an electrochemiluminescence immunoassay
Adam H. Dyer, Helena Dolphin, Antoinette O’Connor, Laura Morrison, Gavin Sedgwick, Conor Young, Emily Killeen, Conal Gallagher, Aoife McFeely, Eimear Connolly, Naomi Davey, Paul Claffey, Paddy Doyle, Shane Lyons, Christine Gaffney, Ruth Ennis, Cathy McHale, Jasmine Joseph, Graham Knight, Emmet Kelly, Cliona O’Farrelly, Aoife Fallon, Sean O’Dowd, Nollaig M. Bourke & Sean P. Kennelly | Biomedcentral | 2024 | View |
Toward a human brain extracellular vesicle atlas: Characteristics of extracellular vesicles from different brain regions, including small RNA and protein profiles
Yiyao Huang, Tanina Arab, Ashley E. Russell, Emily R. Mallick, Rajini Nagaraj, Evan Gizzie, Javier Redding-Ochoa, Juan C. Troncoso, Olga Pletnikova, Andrey Turchinovich, David A. Routenberg, Kenneth W. Witwer | Interdisciplinary Medicine | 2023 | View |
Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome
Lawren VandeVrede, Renaud La Joie, Elisabeth H Thijssen, Breton M Asken, Stephanie A Vento, Torie Tsuei, Suzanne L Baker, Yann Cobigo, Corrina Fonseca, Hilary W Heuer, Joel H Kramer, Peter A Ljubenkov, Gil D Rabinovici, Julio C Rojas, Howie J Rosen, Adam M Staffaroni, Brad F Boeve, Brad C Dickerson, Murray Grossman, Edward D Huey, David J Irwin, Irene Litvan, Alexander Y Pantelyat, Maria Carmela Tartaglia, Jeffrey L Dage, Adam L Boxer | JAMA Neurology | 2023 | View |
Plasma biomarkers for diagnosis of Alzheimer’s disease and prediction of cognitive decline in individuals with mild cognitive impairment
Pia Kivisäkk, Thadryan Sweeney, Becky C. Carlyle, Bianca A. Trombetta, Kathryn LaCasse, Leena El-Mufti, Idil Tuncali, Lori B. Chibnik, Sudeshna Das, Clemens R. Scherzer, Keith A. Johnson, Bradford C. Dickerson, Teresa Gomez-Isla, Deborah Blacker, Derek H. Oakley, Matthew P. Frosch, Bradley T. Hyman, Anahit Aghvanyan, Pradeepthi Bathala, Christopher Campbell, George Sigal, Martin Stengelin, Steven E. Arnold | Frontiers in Neurology | 2023 | View |
Quantitation of neurofilament light chain protein in serum and cerebrospinal fluid from patients with multiple sclerosis using the MSD R-PLEX NfL assay
Antigona Ulndreaj, Dorsa Sohaei, Simon Thebault, Oscar D Pons-Belda, Amaia Fernandez-Uriarte, Christopher Campbell, David Cheo, Martin Stengelin, George Sigal, Mark S Freedman, Isobel A Scarisbrick, Ioannis Prassas, Eleftherios P Diamandis | Diagnosis | 2023 | View |
Lecanemab in Early Alzheimer's Disease
Christopher H van Dyck, Chad J Swanson, Paul Aisen, Randall J Bateman, Christopher Chen, Michelle Gee, Michio Kanekiyo, David Li, Larisa Reyderman, Sharon Cohen, Lutz Froelich, Sadao Katayama, Marwan Sabbagh, Bruno Vellas, David Watson, Shobha Dhadda, Michael Irizarry, Lynn D Kramer, Takeshi Iwatsubo | The New England Journal of Medicine | 2023 | View |
Elevation of neural injury markers in patients with neurologic sequelae after hospitalization for SARS-CoV-2 infection
Michail Spanos, Sigal Shachar, Thadryan Sweeney, H Immo Lehmann, Priyanka Gokulnath, Guoping Li, George B Sigal, Rajini Nagaraj, Pradeepthi Bathala, Farhan Rana, Ravi V Shah, David A Routenberg, Saumya Das | iScience | 2022 | View |
Associations between prognostic index scores and plasma neurofilament light in Huntington's disease
Georgia M Parkin, Jody Corey-Bloom, Jeffrey D Long, Chase Snell, Haileigh Smith, Elizabeth A Thomas | Parkinsonism & Related Disorders | 2022 | View |
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations
Bing Sun, Norina Tang, Michael J. Peluso, Nikita S. Iyer, Leonel Torres, Joanna L. Donatelli, Sadie E. Munter, Christopher C. Nixon, Rachel L. Rutishauser, Isabel Rodriguez-Barraquer, Bryan Greenhouse, John D. Kelly, Jeffrey N. Martin, Steven G. Deeks, Timothy J. Henrich, and Lynn Pulliam | Cells | 2021 | View |
Leptin levels are associated with multiple sclerosis risk
Biström M, Hultdin J, Andersen O, Alonso-Magdalena L, Jons D, Gunnarsson M, Vrethem M, Sundström P | Multiple Sclerosis | 2020 | View |
Early and late effects of maternal experience on hippocampal neurogenesis, microglia, and the circulating cytokine milieu
Rand S. Eid, Jessica A. Chaiton, Stephanie E. Lieblich, Tamara S. Bodnar, Joanne Weinberg, Liisa A.M. Galea | Neurobiology of Aging | 2019 | View |
Altered maternal immune networks are associated with adverse child neurodevelopment: Impact of alcohol consumption during pregnancy
Tamara S. Bodnar, Charlis Raineki, Wladimir Wertelecki, Lyubov Yevtushok, Larisa Plotka, Natalya Zymak-Zakutnya, Gordon Honerkamp-Smith, Alan Wells, Matthieu Rolland, Todd S. Woodward, Claire D. Coles, Julie A. Kable, Christina D. Chambers, Joanne Weinberg, and Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) | Brain, Behavior, and Immunity | 2019 | View |
CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer’s disease
Jonathan D. Cherry , Thor D. Stein, Yorghos Tripodis, Victor E. Alvarez, Bertrand R. Huber, Rhoda Au, Patrick T. Kiernan, Daniel H. Daneshvar, Jesse Mez, Todd M. Solomon, Michael L. Alosco, Ann C. McKee | PLOS ONE | 2017 | View |
Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-β Concentration.
Toombs J, Foiani MS, Paterson RW, Heslegrave A, Wray S, Schott JM, Fox NC, Lunn MP, Blennow K, Zetterberg H. | J Alzheimers Dis. | 2017 | View |
Inflammation in schizophrenia: cytokine levels and their relationships to demographic and clinical variables.
Lee EE, Hong S, Martin AS, Eyler LT, Jeste DV. | Am J Geriatr Psychiatry. | 2017 | View |
Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration.
Höglund K, Kern S, Zettergren A, Börjesson-Hansson A, Zetterberg H, Skoog I, Blennow K. | Translational Psychiatry | 2017 | View |
Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.
Notter T, Coughlin JM, Gschwind T, Weber-Stadlbauer U, Wang Y, Kassiou M, Vernon AC, Benke D, Pomper MG, Sawa A, Meyer U. | Mol Psychiatry. | 2017 | View |
Ablation of Prion Protein in Wild Type Human Amyloid Precursor Protein (APP) Transgenic Mice Does Not Alter The Proteolysis of APP, Levels of Amyloid-β or Pathologic Phenotype.
Whitehouse IJ, Brown D, Baybutt H, Diack AB, Kellett KA, Piccardo P, Manson JC, Hooper NM. | PLoS One. | 2016 | View |
Abnormalities in chemokine levels in schizophrenia and their clinical correlates.
Hong S, Lee EE, Martin AS, Soontornniyomkij B, Soontornniyomkij V, Achim CL, Reuter C, Irwin MR, Eyler LT, Jeste DV. | Schizophr Res. | 2016 | View |
Administrations of human adult ischemia-tolerant mesenchymal stem cells and factors reduce amyloid beta pathology in a mouse model of Alzheimer's disease.
Harach T, Jammes F, Muller C, Duthilleul N, Cheatham V, Zufferey V, Cheatham D, Lukasheva YA, Lasser T, Bolmont T. | Neurobiol Aging. | 2016 | View |
Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer Disease.
Steen Jensen C, Portelius E, Siersma V, Høgh P, Wermuth L, Blennow K, Zetterberg H, Waldemar G, Gregers Hasselbalch S, Hviid Simonsen A. | Dement Geriatr Cogn Disord. | 2016 | View |
CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation.
Kuhlmann J, Andreasson U, Pannee J, Bjerke M, Portelius E, Leinenbach A, Bittner T, Korecka M, Jenkins RG, Vanderstichele H, Stoops E, Lewczuk P, Shaw LM, Zegers I, Schimmel H, Zetterberg H, Blennow K; IFCC Working Group on Standardization of CSF proteins (WG-CSF). | Clin Chim Acta. | 2016 | View |
Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?
Föcking M, Dicker P, Lopez LM, et al. | BMC Psychiatry. | 2016 | View |
Gray matter regions statistically mediating the cross-sectional association of eotaxin and set-shifting among older adults with major depressive disorder.
Smagula SF, Karim HT, Lenze EJ, Butters MA, Wu GF, Mulsant BH, Reynolds CF 3rd, Aizenstein HJ. | Int J Geriatr Psychiatry. | 2016 | View |
Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition.
Schelle J, Häsler L, Göpfert JC, Joos TO, Vanderstichele H, Stoops E, Mandelkow EM, Neumann U, Shimshek DR, Staufenbiel M, Jucker M, Kaeser SA. | Alzheimers Dement. | 2016 | View |
Validation of a commercial chemiluminescence immunoassay for the simultaneous measurement of three different amyloid-β peptides in human cerebrospinal fluid and application to a clinical cohort.
Klafki HW, Hafermann H, Bauer C, Haussmann U, Kraus I, Schuchhardt J, Muck S, Scherbaum N, Wiltfang J. | J Alzheimers Dis. | 2016 | View |
Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer’s disease mouse model.
Fol R, Braudeau J, Ludewig S, Abel T, Weyer SW, Roederer JP, Brod F, Audrain M, Bemelmans AP, Buchholz CJ, Korte M, Cartier N, Müller UC. | Acta Neuropathol. | 2016 | View |
α-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function.
Kuan WL, Bennett N, He X, Skepper JN, Martynyuk N, Wijeyekoon R, Moghe PV, Williams-Gray CH, Barker RA. | Exp Neurol. | 2016 | View |
An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome.
Belichenko PV, Madani R, Rey-Bellet L, Pihlgren M, Becker A, Plassard A, Vuillermot S, Giriens V, Nosheny RL, Kleschevnikov AM, Valletta JS, Bengtsson SK, Linke GR, Maloney MT, Hickman DT, Reis P, Granet A, Mlaki D, Lopez-Deber MP, Do L, Singhal N, Masliah E, Pearn ML, Pfeifer A, Muhs A, Mobley WC. | PLoS One. | 2016 | View |
Brain Amyloid-β Plays an Initiating Role in the Pathophysiological Process of the PS1V97L-Tg Mouse Model of Alzheimer's Disease.
Wang W, Lu L, Wu QQ, Jia JP. | J Alzheimers Dis. | 2016 | View |
Conversion of Synthetic Aβ to In Vivo Active Seeds and Amyloid Plaque Formation in a Hippocampal Slice Culture Model.
Novotny R, Langer F, Mahler J, Skodras A, Vlachos A, Wegenast-Braun BM, Kaeser SA, Neher JJ, Eisele YS, Pietrowski MJ, Nilsson KP, Deller T, Staufenbiel M, Heimrich B, Jucker M. | J Neurosci. | 2016 | View |
Immunological biomarkers associated with brain structure and executive function in late-life depression: exploratory pilot study.
Smagula SF, Lotrich FE, Aizenstein HJ, Diniz BS, Krystek J, Wu GF, Mulsant BH, Butters MA, Reynolds CF 3rd, Lenze EJ. | Int J Geriatr Psychiatry. | 2016 | View |
In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [11C]DPA-713 PET and analysis of CSF and plasma.
Coughlin JM, Wang Y, Ambinder EB, Ward RE, Minn I, Vranesic M, Kim PK, Ford CN, Higgs C, Hayes LN, Schretlen DJ, Dannals RF, Kassiou M, Sawa A, Pomper MG. | Transl Psychiatry. | 2016 | View |
Multiplex analyte assays to characterize different dementias: brain inflammatory cytokines in poststroke and other dementias.
Chen A, Oakley AE, Monteiro M, Tuomela K, Allan LM, Mukaetova-Ladinska EB, O'Brien JT, Kalaria RN. | Neurobiol Aging. | 2016 | View |
Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology.
Olmos-Alonso A, Schetters ST, Sri S, Askew K, Mancuso R, Vargas-Caballero M, Holscher C, Perry VH, Gomez-Nicola D. | Brain. 2016 Mar;139(Pt 3):891-907. | 2016 | View |
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD).
Williams-Gray CH, Wijeyekoon R, Yarnall AJ, Lawson RA, Breen DP, Evans JR, Cummins GA, Duncan GW, Khoo TK, Burn DJ, Barker RA; ICICLE-PD study group. | Mov Disord. | 2016 | View |
Accumulation of murine amyloid-β mimics early Alzheimer’s disease.
Krohn M, Bracke A, Avchalumov Y, Schumacher T, Hofrichter J, Paarmann K, Fröhlich C, Lange C, Brüning T, von Bohlen Und Halbach O, Pahnke J. | Brain | 2015 | View |
Alterations in Brain Inflammation, Synaptic Proteins, and Adult Hippocampal Neurogenesis during Epileptogenesis in Mice Lacking Synapsin2.
Chugh D, Ali I, Bakochi A, Bahonjic E, Etholm L, Ekdahl CT. | PLoS One. | 2015 | View |
Closed Head Injury in an Age-Related Alzheimer Mouse Model Leads to an Altered Neuroinflammatory Response and Persistent Cognitive Impairment.
Webster SJ, Van Eldik LJ, Watterson DM, Bachstetter AD. | J Neurosci. | 2015 | View |
Common Genetic Variant Association with Altered HLA Expression, Synergy with Pyrethroid Exposure, and Risk for Parkinson’s Disease: An Observational and Case–Control Study.
Kannarkat GT, Cook DA, Lee JK, Chang J, Chung J, Sandy E, Paul KC, Ritz B, Bronstein J, Factor SA, Boss JM, Tansey MG. | NPJ Parkinsons Dis. | 2015 | View |
Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ42 using Meso Scale Discovery Assays for Alzheimer's Disease.
Pan C, Korff A, Galasko D, Ginghina C, Peskind E, Li G, Quinn J, Montine TJ, Cain K, Shi M, Zhang J. | J Alzheimers Dis. | 2015 | View |
Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial.
Butchart J, Brook L, Hopkins V, Teeling J, Püntener U, Culliford D, Sharples R, Sharif S, McFarlane B, Raybould R, Thomas R, Passmore P, Perry VH, Holmes C. | Neurology | 2015 | View |
Genetic ablation of soluble tumor necrosis factor with preservation of membrane tumor necrosis factor is associated with neuroprotection after focal cerebral ischemia.
Madsen PM, Clausen BH, Degn M, Thyssen S, Kristensen LK, Svensson M, Ditzel N, Finsen B, Deierborg T, Brambilla R, Lambertsen KL. | J Cereb Blood Flow Metab. | 2015 | View |
Impact of peripheral myeloid cells on amyloid-β pathology in Alzheimer's disease-like mice.
Prokop S, Miller KR, Drost N, Handrick S, Mathur V, Luo J, Wegner A, Wyss-Coray T, Heppner FL. | J Exp Med. | 2015 | View |
Increased CSF biomarkers of angiogenesis in Parkinson disease.
Janelidze S, Lindqvist D, Francardo V, Hall S, Zetterberg H, Blennow K, Adler CH, Beach TG, Serrano GE, van Westen D, Londos E, Cenci MA, Hansson O. | Neurology | 2015 | View |
Increased CSF E-Selectin in Clinical Alzheimer's Disease without Altered CSF Aβ42 and Tau.
Li G, Xiong K, Korff A, Pan C, Quinn JF, Galasko DR, Liu C, Montine TJ, Peskind ER, Zhang J. | J Alzheimers Dis. | 2015 | View |
Mutant Huntingtin Does Not Affect the Intrinsic Phenotype of Human Huntington’s Disease T Lymphocytes.
Miller JR, Träger U, Andre R, Tabrizi SJ. | PLoS One. | 2015 | View |
Role of fractalkine–CX3CR1 pathway in seizure-induced microglial activation, neurodegeneration, and neuroblast production in the adult rat brain.
Ali I, Chugh D, Ekdahl CT. | Neurobiol Dis. | 2015 | View |
Temporal profile of M1 and M2 responses in the hippocampus following early 24 h of neurotrauma.
Ansari MA. | J Neurol Sci. 2015 Oct 15;357(1-2):41-9. | 2015 | View |
The APP Intracellular Domain Is Required for Normal Synaptic Morphology, Synaptic Plasticity, and Hippocampus-Dependent Behavior.
Klevanski M, Herrmann U, Weyer SW, Fol R, Cartier N, Wolfer DP, Caldwell JH, Korte M, Müller UC. | J Neurosci. | 2015 | View |